title: A retrospective evaluation of 56 patients with oral burning and limited clinical findings.
abstract: This study retrospectively evaluated the charts of 56 patients who had been referred to an oral medicine clinic between 1995 and 2004 with oral burning and limited clinical findings. Of the 56 patients, 35 had a final diagnosis of essential burning mouth disorder (EBMD). Five patients with EBMD had a family history of diabetes and two had been diagnosed with late-onset diabetes. Other oral burning diagnoses included sialoadenitis (burning lips syndrome), irritation or allergic reactions to triclosan, diabetic neuropathy, subclinical oral candidiasis, nutritional deficiency/neuropathy, and a drug reaction to an ACE inhibitor (scalded mouth syndrome) that resulted in oral burning.
authors.affiliation: Department of Oral Diagnostic Services, Howard University College of Dentistry, Washington, DC, USA.
authors.forename: Ronald S
authors.initials: RS
authors.lastname: Brown
authors.forename: Andre A
authors.initials: AA
authors.lastname: Farquharson
authors.forename: Frances E
authors.initials: FE
authors.lastname: Sam
authors.forename: Errol
authors.initials: E
authors.lastname: Reid
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000485:Allergens / Q000009:adverse effects; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D000891:Anti-Infective Agents, Local / Q000009:adverse effects; D002054:Burning Mouth Syndrome / Q000175:diagnosis* / Q000209:etiology; D002180:Candidiasis, Oral / Q000150:complications; D002216:Captopril / Q000009:adverse effects; D048909:Diabetes Complications / Q000235:genetics; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003929:Diabetic Neuropathies / Q000150:complications; D003937:Diagnosis, Differential; D004342:Drug Hypersensitivity / Q000150:complications; D005260:Female; D006801:Humans; D007509:Irritants / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009748:Nutrition Disorders / Q000150:complications; D012189:Retrospective Studies; D012793:Sialadenitis / Q000150:complications; D014260:Triclosan / Q000009:adverse effects
chemical_list: D000485:Allergens; D000806:Angiotensin-Converting Enzyme Inhibitors; D000891:Anti-Infective Agents, Local; D007509:Irritants; D014260:Triclosan; D002216:Captopril